Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
367
datasets available to search
ShareScore release 0.9.0
Dataset results
367 results for “Ibrutinib”
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT05254743. IPD Sharing: YES. Countries: 23. Publications: 0.
INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)
ClinicalTrials.gov study NCT03424122. IPD Sharing: NO. Countries: 3. Publications: 0.
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT03223610. IPD Sharing: YES. Countries: 1. Publications: 1.
Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma
ClinicalTrials.gov study NCT02884453. IPD Sharing: NO. Countries: 1. Publications: 2.
Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02356458. IPD Sharing: NO. Countries: 3. Publications: 1.
A Study to Determine the Absorption, Metabolism, and Routes of Excretion of (14C) Radiolabeled Ibrutinib in Healthy Male Participants
ClinicalTrials.gov study NCT01674322. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03479268. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
ClinicalTrials.gov study NCT02756247. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Study of Lenalidomide, Rituximab and Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02200848. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02169180. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD.
ClinicalTrials.gov study NCT04639362. IPD Sharing: NO. Countries: 2. Publications: 1.
Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02427620. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors
ClinicalTrials.gov study NCT03525925. IPD Sharing: NO. Countries: 1. Publications: 1.
A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02460276. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia
ClinicalTrials.gov study NCT01841723. IPD Sharing: YES. Countries: 1. Publications: 1.
A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients
ClinicalTrials.gov study NCT02558816. IPD Sharing: NO. Countries: 2. Publications: 2.
Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL
ClinicalTrials.gov study NCT02682641. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 2 Study to Assess Activity & Safety of Front-line Ibrutinib + Rituximab in Unfit Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02232386. IPD Sharing: NO. Countries: 1. Publications: 1.
Sequential Regimen of Bendamustin [B] Followed by GA101 and Ibrutinib [I] in CLL Patients
ClinicalTrials.gov study NCT02345863. IPD Sharing: NO. Countries: 1. Publications: 3.
Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04234061. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.